Product Information
DICYCLOMINE 10 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0777 per EA under NDC 16571026001. Its NADAC has been published 32 times since Feb 25, 2026.
FDA first approved this application on Jun 23, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571026001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICYCLOMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA219242FDA Approved
6/23/2025
TE Code
AB
On Market Since
6/23/2025
Pharmacological Classes
Price Statistics
The NADAC for DICYCLOMINE 10 MG CAPSULE has been published 32 times since Feb 25, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0777 per EA |
|---|---|
| All-time high | $0.0779 (Mar 11, 2026) |
| All-time low | $0.0752 (Jul 22, 2026) |
| 52-week high | $0.0779 |
| 52-week low | $0.0752 |
| Median price | $0.0760 |
| Average price | $0.0761 |
| Largest weekly change | -3.3% (Mar 18, 2026) |
| Weeks tracked | 32 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DICYCLOMINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICYCLOMINE 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DICYCLOMINE 10 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0777 per EA (NDC 16571026001), effective Sep 30, 2026.
How has the price of DICYCLOMINE 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DICYCLOMINE 10 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 32 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for DICYCLOMINE 10 MG CAPSULE?
Since Feb 25, 2026, the NADAC for DICYCLOMINE 10 MG CAPSULE has ranged from a low of $0.0752 (Jul 22, 2026) to a high of $0.0779 (Mar 11, 2026), with a median of $0.0760 per EA.
Are there cheaper alternatives to DICYCLOMINE 10 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DICYCLOMINE 10 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DICYCLOMINE 10 MG CAPSULE?
DICYCLOMINE 10 MG CAPSULE (NDC 16571026001) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.